Dewan Taslima Akhter
Research Subjects
Dewan Taslima Akhter has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Kristofer J. Thurecht
The University of Queensland
3 shared publications - Nicholas L. Fletcher
University of Queensland
3 shared publications - Andrew K. Whittaker
ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide (GETCO2), The University of Queensland, Brisbane, Australia
1 shared publication Anne K. Lagendijk
Institute for Molecular Bioscience
1 shared publication- Bing Zhang
Department of Agriculture and Fisheries , Brisbane, Queensland 4102
1 shared publication - Changkui Fu
Australian Institute for Bioengineering and Nanotechnology The University of Queensland St Lucia Queensland 4072 Australia
1 shared publication
Latest Publications
- 14 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (3) , 3132-3155
Trans-Endothelial Trafficking in Zebrafish: Nanobio Interactions of Polyethylene Glycol-Based Nanoparticles in Live Vasculature
Trans-endothelial transport of nanoparticles remains poorly characterized in live organisms. The zebrafish is a well-established model for direct in vivo imaging; however, standardized controls have not been consistently applied across studies. Here, we developed a standardized protocol to assess nanoparticle trans-endothelial trafficking in live zebrafish. We identified 2000 kDa dextran as an optimal coinjection control for standardizing microinjections and quantifying nanoparticle transport in a systematic, unbiased manner. Using the standardized protocol, we profiled early physiological trans-endothelial transport pathways in zebrafish embryos using dextran solutes as extravasation markers, showing that steady-state solute extravasation is characterized by paracellular routes selective for solutes cavin1b knock-in zebrafish line. Using cavin1a/cavin1b double knockout zebrafish and tumor-bearing Cavin1 null mice, we showed that caveolae do not contribute to the transvascular transport of these PEG-based nanoparticles. This work demonstrates the rigor of the standardized protocol for assessing trans-endothelial transport in the live zebrafish and provides fundamental cell biology insight into the in vivo behavior of PEG-based nanoparticles.
- 14 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (3) , 3132-3155
Trans-Endothelial Trafficking in Zebrafish: Nanobio Interactions of Polyethylene Glycol-Based Nanoparticles in Live Vasculature
Trans-endothelial transport of nanoparticles remains poorly characterized in live organisms. The zebrafish is a well-established model for direct in vivo imaging; however, standardized controls have not been consistently applied across studies. Here, we developed a standardized protocol to assess nanoparticle trans-endothelial trafficking in live zebrafish. We identified 2000 kDa dextran as an optimal coinjection control for standardizing microinjections and quantifying nanoparticle transport in a systematic, unbiased manner. Using the standardized protocol, we profiled early physiological trans-endothelial transport pathways in zebrafish embryos using dextran solutes as extravasation markers, showing that steady-state solute extravasation is characterized by paracellular routes selective for solutes cavin1b knock-in zebrafish line. Using cavin1a/cavin1b double knockout zebrafish and tumor-bearing Cavin1 null mice, we showed that caveolae do not contribute to the transvascular transport of these PEG-based nanoparticles. This work demonstrates the rigor of the standardized protocol for assessing trans-endothelial transport in the live zebrafish and provides fundamental cell biology insight into the in vivo behavior of PEG-based nanoparticles.
- 31 August 2023
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 35 (17) , 7252-7265
Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery
- 31 August 2023
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 35 (17) , 7252-7265
Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery
- Open Access
- 18 January 2021
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 8
Characterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a Rhipicephalus (Boophilus) microplus Protective Antigen With in vivo Live Animal Imaging
Development of veterinary subunit vaccines comes with a spectrum of challenges, such as the choice of adjuvant, antigen delivery vehicle, and optimization of dosing strategy. Over the years, our laboratory has largely focused on investigating silica vesicles (SVs) for developing effective veterinary vaccines for multiple targets. Rhipicephalus microplus (cattle tick) are known to have a high impact on cattle health and the livestock industry in the tropical and subtropical regions. Development of vaccine using Bm86 antigen against R. microplus has emerged as an attractive alternative to control ticks. In this study, we have investigated the biodistribution of SV in a live animal model, as well as further explored the SV ability for vaccine development. Rhodamine-labeled SV-140-C18 (Rho-SV-140-C18) vesicles were used to adsorb the Cy5-labeled R. microplus Bm86 antigen (Cy5-Bm86) to enable detection and characterization of the biodistribution of SV as well as antigen in vivo in a small animal model for up to 28 days using optical fluorescence imaging. We tracked the in vivo biodistribution of SVs and Bm86 antigen at different timepoints (days 3, 8, 13, and 28) in BALB/c mice. The biodistribution analysis by live imaging as well as by measuring the fluorescent intensity of harvested organs over the duration of the experiment (28 days) showed greater accumulation of SVs at the site of injection. The Bm86 antigen biodistribution was traced in lymph nodes, kidney, and liver, contributing to our understanding how this delivery platform successfully elicits antibody responses in the groups administered antigen in combination with SV. Selected tissues (skin, lymph nodes, spleen, kidney, liver, and lungs) were examined for any cellular abnormalities by histological analysis. No adverse effect or any other abnormalities were observed in the tissues.
- 18 January 2021
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 8
Open AccessCharacterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a Rhipicephalus (Boophilus) microplus Protective Antigen With in vivo Live Animal Imaging
Development of veterinary subunit vaccines comes with a spectrum of challenges, such as the choice of adjuvant, antigen delivery vehicle, and optimization of dosing strategy. Over the years, our laboratory has largely focused on investigating silica vesicles (SVs) for developing effective veterinary vaccines for multiple targets. Rhipicephalus microplus (cattle tick) are known to have a high impact on cattle health and the livestock industry in the tropical and subtropical regions. Development of vaccine using Bm86 antigen against R. microplus has emerged as an attractive alternative to control ticks. In this study, we have investigated the biodistribution of SV in a live animal model, as well as further explored the SV ability for vaccine development. Rhodamine-labeled SV-140-C18 (Rho-SV-140-C18) vesicles were used to adsorb the Cy5-labeled R. microplus Bm86 antigen (Cy5-Bm86) to enable detection and characterization of the biodistribution of SV as well as antigen in vivo in a small animal model for up to 28 days using optical fluorescence imaging. We tracked the in vivo biodistribution of SVs and Bm86 antigen at different timepoints (days 3, 8, 13, and 28) in BALB/c mice. The biodistribution analysis by live imaging as well as by measuring the fluorescent intensity of harvested organs over the duration of the experiment (28 days) showed greater accumulation of SVs at the site of injection. The Bm86 antigen biodistribution was traced in lymph nodes, kidney, and liver, contributing to our understanding how this delivery platform successfully elicits antibody responses in the groups administered antigen in combination with SV. Selected tissues (skin, lymph nodes, spleen, kidney, liver, and lungs) were examined for any cellular abnormalities by histological analysis. No adverse effect or any other abnormalities were observed in the tissues.
- 28 April 2020
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 21 (6) , 2320-2333
Direct Comparison of Poly(ethylene glycol) and Phosphorylcholine Drug-Loaded Nanoparticles In Vitro and In Vivo
Phosphorylcholine is known to repel the absorption of proteins onto surfaces, which can prevent the formation of a protein corona on the surface of nanoparticles. This can influence the fate of nanoparticles used for drug delivery. This material could therefore serve as an alternative to poly(ethylene glycol) (PEG). Herein, the synthesis of different particles prepared by polymerization induced self-assembly (PISA) coated with either poly(ethylene glycol) (PEG) or zwitterionic 2-methacryloyloxyethyl phosphorylcholine (MPC) and PENAO were reported. The anti-cancer drug PENAO (4-(N-(S-penicillaminylacetyl)amino) phenylarsenonous acid) was conjugated to the shell-forming block. Interactions of the different coated nanoparticles – that represent comparable sizes and size distributions (76 – 85 nm, PDI = 0.0067 - 0.0094) – with 2D and 3D cultured cells were studied and their cytotoxicity, cellular uptake, spheroid penetration and cell localization profile was analyzed. While only a minimal difference between the nanoparticles for the conducted in vitro experiments were seen (with PEG-co-PENAO coated micelles showing slightly higher cytotoxicity, better spheroid penetration and cell localization ability), the study was amplified when in vivo biodistribution studies were conducted. After 1 hour postinjection, the majority of the MPC-co-PENAO coated nanoparticles were found to accumulate in the liver, making this particle system unfeasible for future studies.
- 28 April 2020
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 21 (6) , 2320-2333
Direct Comparison of Poly(ethylene glycol) and Phosphorylcholine Drug-Loaded Nanoparticles In Vitro and In Vivo
Phosphorylcholine is known to repel the absorption of proteins onto surfaces, which can prevent the formation of a protein corona on the surface of nanoparticles. This can influence the fate of nanoparticles used for drug delivery. This material could therefore serve as an alternative to poly(ethylene glycol) (PEG). Herein, the synthesis of different particles prepared by polymerization induced self-assembly (PISA) coated with either poly(ethylene glycol) (PEG) or zwitterionic 2-methacryloyloxyethyl phosphorylcholine (MPC) and PENAO were reported. The anti-cancer drug PENAO (4-(N-(S-penicillaminylacetyl)amino) phenylarsenonous acid) was conjugated to the shell-forming block. Interactions of the different coated nanoparticles – that represent comparable sizes and size distributions (76 – 85 nm, PDI = 0.0067 - 0.0094) – with 2D and 3D cultured cells were studied and their cytotoxicity, cellular uptake, spheroid penetration and cell localization profile was analyzed. While only a minimal difference between the nanoparticles for the conducted in vitro experiments were seen (with PEG-co-PENAO coated micelles showing slightly higher cytotoxicity, better spheroid penetration and cell localization ability), the study was amplified when in vivo biodistribution studies were conducted. After 1 hour postinjection, the majority of the MPC-co-PENAO coated nanoparticles were found to accumulate in the liver, making this particle system unfeasible for future studies.
- 18 December 2018
- Published by University of Queensland Library
Development of novel polymeric theranostic for the treatment of colorectal cancer
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- 18 December 2018
- Published by University of Queensland Library
Development of novel polymeric theranostic for the treatment of colorectal cancer
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.